Mitesh

The Government has yet to conclude consideration of any increases to prescription charges and prescription pre-payment certificates (PPCs) for 2025/26. The current charges will therefore roll over into April 2025. Community Pharmacy England will update community pharmacy teams as soon as any changes are announced by Ministers, including details of when they will be implemented. [...]

The post £9.90 NHS prescription charge unchanged for April 2025 appeared first on Community Pharmacy England.

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (20/03/2025) announced the following list of price concessions for March 2025: Drug Pack size Price concession Acamprosate 333mg gastro-resistant tablets 168 £21.65 Alendronic acid 70mg tablets 4 £1.21 [...]

The post March 2025 Price Concessions 2nd Update appeared first on Community Pharmacy England.

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (18/03/2025) announced the following initial list of price concessions for March 2025: Drug  Pack size Price concession Alfuzosin 2.5mg tablets 60 £4.46 Bimatoprost 300micrograms/ml / Timolol 5mg/ml eye [...]

The post March 2025 Price Concessions 1st Update appeared first on Community Pharmacy England.

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (18/03/2025) announced the following initial list of price concessions for March 2025: Drug  Pack size Price concession Alfuzosin 2.5mg tablets 60 £4.46 Bimatoprost 300micrograms/ml / Timolol 5mg/ml eye [...]

The post March 2025 Price Concessions 1st Update appeared first on Community Pharmacy England.

Drug alert number: EL (25)A/10 Date issued: 4 March 2025 Aspar Pharmaceuticals Limited have informed the MHRA of an error related to a batch of Boots Paracetamol 500 mg tablets (16s). The foil blister inside the carton incorrectly states ‘Aspirin 300 mg Dispersible Tablets’. The tablets are confirmed to be Paracetamol 500 mg tablets. Boots [...]

The post MHRA Class 2 Medicines recall: Paracetamol 500 mg tablets (16s) (Boots) appeared first on Community Pharmacy England.